These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


789 related items for PubMed ID: 8543829

  • 1. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD, Hester CG, Frank MM.
    J Immunol; 1996 Jan 15; 156(2):749-57. PubMed ID: 8543829
    [Abstract] [Full Text] [Related]

  • 2. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD, Frank MM.
    J Clin Invest; 1972 Mar 15; 51(3):583-9. PubMed ID: 4622104
    [Abstract] [Full Text] [Related]

  • 3. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 15; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 4. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation.
    Pluschke G, Bordmann G, Daoudaki ME, Lambris JD, Achtman M, Neibert M.
    Eur J Immunol; 1989 Jan 15; 19(1):131-5. PubMed ID: 2646134
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of immune precipitation by complement.
    Hong K, Takata Y, Sayama K, Kozono H, Takeda J, Nakano Y, Kinoshita T, Inoue K.
    J Immunol; 1984 Sep 15; 133(3):1464-70. PubMed ID: 6747294
    [Abstract] [Full Text] [Related]

  • 6. C4 does not bind to human and rabbit IgM during activation of the classical complement pathway on the red cell.
    Circolo A, Borsos T.
    J Immunol; 1982 Oct 15; 129(4):1485-8. PubMed ID: 7108214
    [Abstract] [Full Text] [Related]

  • 7. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
    Füst G, Medgyesi GA, Rajnavölgyi E, Csécsi-Nagy M, Czikora K, Gergely J.
    Immunology; 1978 Dec 15; 35(6):873-84. PubMed ID: 104923
    [Abstract] [Full Text] [Related]

  • 8. Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes.
    Fuson EW, Shaw MW, Hubbard RA, Lamon EW.
    Clin Exp Immunol; 1979 Oct 15; 38(1):158-65. PubMed ID: 316751
    [Abstract] [Full Text] [Related]

  • 9. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.
    Russell MW, Reinholdt J, Kilian M.
    Eur J Immunol; 1989 Dec 15; 19(12):2243-9. PubMed ID: 2606139
    [Abstract] [Full Text] [Related]

  • 10. Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.
    Rajnavölgyi E, Fazekas G, Lund J, Daeron M, Teillaud JL, Jefferis R, Fridman WH, Gergely J.
    Immunology; 1995 Apr 15; 84(4):645-52. PubMed ID: 7540592
    [Abstract] [Full Text] [Related]

  • 11. Complement fixation by rheumatoid factor.
    Tanimoto K, Cooper NR, Johnson JS, Vaughan JH.
    J Clin Invest; 1975 Mar 15; 55(3):437-45. PubMed ID: 1078825
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
    Garred P, Michaelsen TE, Aase A, Mollnes TE.
    J Immunol; 1990 Jan 01; 144(1):198-203. PubMed ID: 2295791
    [Abstract] [Full Text] [Related]

  • 14. Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation.
    Rieben R, Roos A, Muizert Y, Tinguely C, Gerritsen AF, Daha MR.
    Blood; 1999 Feb 01; 93(3):942-51. PubMed ID: 9920844
    [Abstract] [Full Text] [Related]

  • 15. The immunoglobulin and complement levels in the active pulmonary sarcoidosis.
    Cagatay T, Bilir M, Gulbaran M, Papila C, Cagatay P.
    Kobe J Med Sci; 2003 Feb 01; 49(5-6):99-106. PubMed ID: 15141145
    [Abstract] [Full Text] [Related]

  • 16. The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes.
    Kauffmann RH, de Rooy-Dijk HH, Klein F, Lafeber GJ, Cats A, van Es LA.
    Clin Exp Immunol; 1983 Oct 01; 54(1):203-12. PubMed ID: 6311469
    [Abstract] [Full Text] [Related]

  • 17. The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation.
    Stewart WW, Johnson A, Steward MW, Whaley K, Kerr MA.
    Mol Immunol; 1988 Dec 01; 25(12):1355-61. PubMed ID: 3266294
    [Abstract] [Full Text] [Related]

  • 18. Anti-immunoglobulin autoantibodies are not preferentially induced in polyclonal activation of human and mouse lymphocytes, and more anti-DNA and anti-erythrocyte autoantibodies are induced in polyclonal activation of mouse than human lymphocytes.
    Dziarski R.
    J Immunol; 1984 Nov 01; 133(5):2537-44. PubMed ID: 6207235
    [Abstract] [Full Text] [Related]

  • 19. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
    Lucisano Valim YM, Lachmann PJ.
    Clin Exp Immunol; 1991 Apr 01; 84(1):1-8. PubMed ID: 1707767
    [Abstract] [Full Text] [Related]

  • 20. Activation of rat complement by soluble and insoluble rat IgA immune complexes.
    Rits M, Hiemstra PS, Bazin H, Van Es LA, Vaerman JP, Daha MR.
    Eur J Immunol; 1988 Dec 01; 18(12):1873-80. PubMed ID: 3220102
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.